📄 VOGENX, INC. ($VOGX)

Vogenx, Inc. is a pharmaceutical company focused on the development of mizagliflozin. The company intends to use proceeds from its initial public offering to fund the continued development of this drug candidate, along with general corporate purposes and working capital. Key risk: Investment in our common stock involves substantial risks. Proceeds: fund the continued development of mizagliflozin, payment of accrued expenses, additional research and development, general corporate purposes, working capital

Vogenx, Inc. is a pharmaceutical company focused on the development of mizagliflozin. The company intends to use proceeds from its initial public offering to fund the continued development of this drug candidate, along with general corporate purposes and working capital.